Admissions

• California
• Massachusetts

Recognitions

From 2017 through 2019, Chambers has ranked Matt as Band 5 in product liability and mass torts. In 2017 and 2018, Legal 500 ranked him as a "Next Generation Lawyer," and in 2015 and 2016, Chambers recognized Matt as "Up and Coming." Clients have commented that Matt is "incredibly smart and practical – he can shape effective strategies in understandable and presentable ways"; he "has a great way of explaining issues in a user-friendly way," with a "very good sense of . . . business issues"; and he is "the type of lawyer who really gets invested in your interests." Other clients have said Matt is "absolutely detail-oriented and on top of every issue in the case." In 2018 and 2019, Matt was selected for inclusion in Who's Who Legal: Life Sciences for Product Liability.

Education

• J.D., Stanford University 2000
  Order of the Coif
  Research Assistant to Dean Kathleen Sullivan
  Teaching Assistant, Federal Litigation
  Associate Editor, Stanford Law Review
  Senior Editor, Stanford Law and Policy Review
  Co-President, Stanford Law Students Association
• B.A., Harvard University 1995
  magna cum laude
  Social Studies
  Phi Beta Kappa
  Truman Scholar

Courts

• All California state and federal district courts
• All Massachusetts state courts
• United States Court of Appeals for the Seventh Circuit
• United States District Court for the District of Massachusetts

Memberships

• Boston Bar Association (2006 – present)
• Defense Research Institute (2003 – present)
• Local Rules Committee, US District Court for Southern District of California (2002 – 2003)

Clerkships and Other Relevant Professional Experience

• Law Clerk to the Honorable Charles R. Breyer, US District Court for the Northern District of California (2000 – 2001)
• Extern to the Honorable Napoleon A. Jones, US District Court for the Southern District of California (1998)
• Teaching Experience: Matt has taught, co-taught or prepared lectures on the following topics for courses at Harvard Law School and Yale Law School: (1) the regulatory system governing pharmaceutical, biotech and medical device companies; (2) how to litigate complex multi-jurisdictional product liability suits, including the coordination of these cases with related litigation such as government investigations, securities litigation, trade secret litigation and putative class actions; (3) the use of scientific data and other expert evidence in complex litigation; (4) the selection of plaintiffs for bellwether trials in mass torts; (5) the resolution of mass torts; and (6) the role of lawyers as strategic advisors.